Literature DB >> 27798884

High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.

Bolag Altan1,2, Takehiko Yokobori1,3, Munenori Ide4, Tuya Bai5, Toru Yanoma5, Akiharu Kimura5, Norimichi Kogure5, Masaki Suzuki5, Pinjie Bao5, Erito Mochiki6, Kyoichi Ogata5, Tadashi Handa4, Kyoichi Kaira2, Masahiko Nishiyama3, Takayuki Asao7, Tetsunari Oyama4, Hiroyuki Kuwano5.   

Abstract

BACKGROUND: The MRN complex of meiotic recombination 11 (MRE11), DNA repair protein Rad50 (RAD50) and Nijmegen breakage syndrome 1 (NBS1) proteins coordinate the detection and repair of DNA double-strand breaks (DSBs). DNA DSB repair-dependent chemoresistance likely has an effect on the treatment of human cancer.
MATERIALS AND METHODS: We investigated the expression of MRN complex in human gastric cancer (GC) tissues using immunohistochemistry and analyzed its clinical significance and prognostic relevance.
RESULTS: The expression of MRN complex was significantly associated with clinical factors including poorer prognosis and negatively associated with the expression of DNA damage marker phosphorylated H2A histone family, member X (γH2AX) in the nucleus. In the biopsy specimens, low expression of MRE11 correlated with good response to chemotherapy and surgical resection after down-staging by chemotherapy. Furthermore, the expression levels of MRE11 and RAD50 were independent predictors of surgical resection after chemotherapy.
CONCLUSION: The high expression of MRN complex constituents could be a predictor for poor prognosis and chemoresistance in GC. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  DSB; Double-strand break repair; MRN complex; cisplatin; paclitaxel

Mesh:

Substances:

Year:  2016        PMID: 27798884     DOI: 10.21873/anticanres.11094

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  21 in total

1.  [Bioinformatics analysis of expression and function of EXD3 gene in gastric cancer].

Authors:  Dengzhong Sun; Mulin Liu; Fuxin Huang; Fuxin Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

2.  Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma.

Authors:  Joel Del Bel Pádua; Carolline Fontes Alves Mariano; Alexandre Todorovic Fabro; Daniela Pretti da Cunha Tirapelli; Ajith Kumar Sankarankutty; José Sebastião Dos Santos; Mariângela Ottoboni Brunaldi
Journal:  J Histochem Cytochem       Date:  2022-01-03       Impact factor: 2.479

3.  Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.

Authors:  Adel Alblihy; Reem Ali; Mashael Algethami; Ahmed Shoqafi; Michael S Toss; Juliette Brownlie; Natalie J Tatum; Ian Hickson; Paloma Ordonez Moran; Anna Grabowska; Jennie N Jeyapalan; Nigel P Mongan; Emad A Rakha; Srinivasan Madhusudan
Journal:  NPJ Precis Oncol       Date:  2022-07-19

Review 4.  The molecular mechanisms of chemoresistance in cancers.

Authors:  Hua-Chuan Zheng
Journal:  Oncotarget       Date:  2017-07-06

Review 5.  Writing, erasing and reading histone lysine methylations.

Authors:  Kwangbeom Hyun; Jongcheol Jeon; Kihyun Park; Jaehoon Kim
Journal:  Exp Mol Med       Date:  2017-04-28       Impact factor: 8.718

6.  Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.

Authors:  Vincent Ho; Liping Chung; Amandeep Singh; Vivienne Lea; Askar Abubakar; Stephanie H Lim; Weng Ng; Mark Lee; Paul de Souza; Joo-Shik Shin; Cheok Soon Lee
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

Review 7.  Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Authors:  Zeinab Safarpour Lima; Mostafa Ghadamzadeh; Farzad Tahmasebi Arashloo; Ghazaleh Amjad; Mohammad Reza Ebadi; Ladan Younesi
Journal:  J Hematol Oncol       Date:  2019-04-11       Impact factor: 17.388

8.  Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival.

Authors:  Zhenyu Xu; Yabin Xia; Zhangang Xiao; Yuliang Jia; Lina Li; Yan Jin; Qijie Zhao; Lin Wan; Tao Yi; Yangyang Yu; Qinglian Wen; Yinxin Zhu; Bo Qin; Fan Zhang; Jing Shen
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

9.  Elevated MRE11 expression associated with progression and poor outcome in prostate cancer.

Authors:  Jun Wang; Wen-Hao Xu; Yu Wei; Yao Zhu; Xiao-Jian Qin; Hai-Liang Zhang; Ding-Wei Ye
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

10.  PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.

Authors:  Naoya Ozawa; Takehiko Yokobori; Katsuya Osone; Chika Katayama; Kunihiko Suga; Chika Komine; Yuta Shibasaki; Takuya Shiraishi; Takuhisa Okada; Ryuji Kato; Hiroomi Ogawa; Akihiko Sano; Makoto Sakai; Makoto Sohda; Hitoshi Ojima; Tatsuya Miyazaki; Yoko Motegi; Munenori Ide; Takashi Yao; Hiroyuki Kuwano; Ken Shirabe; Hiroshi Saeki
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.